晨间信号Morning Signal
《新科学家》 2026年10月17日 · 中文解读

癌症精准狙击:按基因突变而非发病部位治疗肿瘤

Cancer in the crosshairs · Alice Klein
约 22 分钟Features在小程序里点播,20 到 60 分钟做好
这篇讲什么
29岁的斯蒂芬·赫夫确诊四期肺癌时,肿瘤已扩散到肺、颈、脊柱、肝和脑。他接受全面基因组检测后发现ALK基因异常,改用靶向药阿来替尼,扫描显示几乎所有肿瘤都缩小或消失。这种精准肿瘤学正让肺癌、胰腺癌、脑癌等曾经的绝症患者活得更久,澳大利亚已在全国免费提供检测。
原文开头
Targeting tumours based on their genetic mutations, rather than their location in the body, is helping people survive even the worst cancers, discovers Alice Klein STEPHEN HUFF was about to get married when he had a scan to investigate why he had been feeling short of breath. He was a fit 29-year-old who had played professional baseball and never smoked, so he wasn’t expecting the diagnosis: stage 4 lung cancer. “I had multiple spots all in my lungs, my neck, my spine, my liver, my brain – just everywhere,” he says. “I put on a brave front, but deep down I was terrified. I didn’t know if I’d be here in six months.” …
摘自《新科学家》(New Scientist)2026年10月17日,Alice Klein。仅引用开头一小段供了解文章,版权归原刊所有,全文请阅读原刊。
晨间信号小程序码
微信扫码,在小程序里听完整版
不用登录先听一篇 · 或在微信搜索小程序 晨间信号
同期其他文章